PSMD3 and acute myeloid leukemia: CDK12 is an oncogene which is up-regulated and has highest expression level in Acute Myeloid Leukemia (AML) (Figure 6D), while its partner boundary non-oncogene PSMD3 shows down-regulation in AML patients (Figure 6E).